- Analysis of the distribution of trial sites in South Korea using social network analysis
-
Huh KY, Yu KS, Song I
- KMID: 2552402
- Transl Clin Pharmacol.
- 2023 Mar;31(1):1-12.
- doi: 10.12793/tcp.2023.31.e2
Location of trial sites can be a potential source of study bias. Considering that clinical trials have been mostly conducted in urban areas, the distribution of trial sites need to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of three-dimensional image based insole for healthy volunteers: a pilot clinical trial
-
Jeong BO, Jeong SJ, Park K, Kim BH, Yim SV, Kim S
- KMID: 2552406
- Transl Clin Pharmacol.
- 2023 Mar;31(1):49-58.
- doi: 10.12793/tcp.2023.31.e5
Insoles are used to treat various foot diseases, including plantar foot, diabetic foot ulcers, and refractory plantar fasciitis. In this study, we investigated the effects of 3-dimensional image-based (3-D) insole... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
-
Kim H, Kim CO, Park H, Park MS, Kim D, Hong T, Shin Y, Jin BH
- KMID: 2552407
- Transl Clin Pharmacol.
- 2023 Mar;31(1):59-68.
- doi: 10.12793/tcp.2023.31.e4
Concomitant administration of lobeglitazone, empagliflozin, and metformin is expected to enhance blood glucose-lowering effects and improve medication compliance in patients with diabetes mellitus. In this study, we investigated the pharmacokinetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation
-
Yang AY, Yoo H, Shin W, Lee YS, Lee H, Kim SE, Kim A
- KMID: 2552405
- Transl Clin Pharmacol.
- 2023 Mar;31(1):40-48.
- doi: 10.12793/tcp.2023.31.e3
Fexuprazan (DWP14012), a potassium-competitive acid blocker, is a medical formulation prescribed to inhibit the secretion of gastric acid. The present study encompasses a comparative evaluation of pharmacokinetic (PK) analysis between... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety assessment of protein supplement - micronutrient fortification in promoting health and wellbeing in healthy adults -a randomized placebo-controlled trial
-
Ambulkar P, Hande P, Tambe B, Vaidya VGV, Naik N, Agarwal R, i Ganu G
- KMID: 2552403
- Transl Clin Pharmacol.
- 2023 Mar;31(1):13-27.
- doi: 10.12793/tcp.2023.31.e1
Protein supplements are extensively used for muscle building, weight loss, recovery from exercise, improving endurance & cardio-performance. Major challenge with protein supplement is undigested protein and impaired gut health which... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of antioxidants in improving semen parameters like count, motility and DNA fragmentation in sub-fertile males: a randomized, double-blind, placebo-controlled clinical trial
-
Patki A, Shelatkar R, Singh M, Agarwal S, M V, Umbardand S, Reddy A, Kannan P, Gorthi S, Khastgir G, Kulshreshtha A, Ganu G
- KMID: 2552404
- Transl Clin Pharmacol.
- 2023 Mar;31(1):28-39.
- doi: 10.12793/tcp.2023.31.e6
Male infertility is solely responsible for 20–30% of infertility cases. Oxidative damage of sperm DNA is positively linked with oligoasthenoteratozoospermia (OAT), and male infertility. The antioxidants are being explored worldwide... -
- CITED
-
- Close
- SHARE
-
- Close
